PER 5.13% 7.4¢ percheron therapeutics limited

If you review the PPMD 'latest research' page they are...

  1. 43 Posts.
    lightbulb Created with Sketch. 3
    If you review the PPMD 'latest research' page they are currently advocating for combinations in therapies with the thesis that they will be more effective. I can't post the link for some reason.

    The way I see it someone like Sarepta would have little to lose by trialling their drug in combo. It keeps good will with the ppmd community and keeps their company and drug front and centre in treatment of this disease. Sarepta are all in on DMD and cannot afford to stand still and watch others beat them to the punch.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.4¢
Change
-0.004(5.13%)
Mkt cap ! $66.71M
Open High Low Value Volume
7.8¢ 7.8¢ 7.2¢ $78.26K 1.049M

Buyers (Bids)

No. Vol. Price($)
1 5919 7.4¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 156164 2
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.